BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.97
  • Today's Change0.002 / 0.21%
  • Shares traded808.60k
  • 1 Year change+13.05%
  • Beta0.2438
Data delayed at least 20 minutes, as of Feb 18 2026 16:42 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments5.6286121
Total Receivables, Net322020
Total Inventory------
Prepaid expenses------
Other current assets, total049--
Total current assets37155140
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments1,1621,2011,224
Note receivable - long term------
Other long term assets------
Total assets1,2001,3571,364
LIABILITIES
Accounts payable141220
Accrued expenses3.363.834.10
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0.9501.95
Total current liabilities181626
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total0.0600.26
Total liabilities181627
SHAREHOLDERS EQUITY
Common stock141414
Additional paid-in capital607607607
Retained earnings (accumulated deficit)561720717
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,1821,3411,337
Total liabilities & shareholders' equity1,2001,3571,364
Total common shares outstanding1,1861,3031,319
Treasury shares - common primary issue1887155
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.